612 related articles for article (PubMed ID: 25269710)
41. Rituximab in the Treatment of Interstitial Lung Disease Associated with Antisynthetase Syndrome: A Multicenter Retrospective Case Review.
Doyle TJ; Dhillon N; Madan R; Cabral F; Fletcher EA; Koontz DC; Aggarwal R; Osorio JC; Rosas IO; Oddis CV; Dellaripa PF
J Rheumatol; 2018 Jun; 45(6):841-850. PubMed ID: 29606668
[TBL] [Abstract][Full Text] [Related]
42. Clinical features and outcomes of the patients with anti-glycyl tRNA synthetase syndrome.
Zhang Y; Ge Y; Yang H; Chen H; Tian X; Huang Z; Liu S; Lu X; Wang G
Clin Rheumatol; 2020 Aug; 39(8):2417-2424. PubMed ID: 32144624
[TBL] [Abstract][Full Text] [Related]
43. A Multidisciplinary Evaluation Helps Identify the Antisynthetase Syndrome in Patients Presenting as Idiopathic Interstitial Pneumonia.
Chartrand S; Swigris JJ; Peykova L; Chung J; Fischer A
J Rheumatol; 2016 May; 43(5):887-92. PubMed ID: 26932342
[TBL] [Abstract][Full Text] [Related]
44. Myositis-associated interstitial lung disease.
Vu TTT; Brown KK; Solomon JJ
Curr Opin Pulm Med; 2023 Sep; 29(5):427-435. PubMed ID: 37435671
[TBL] [Abstract][Full Text] [Related]
45. Evolution of Pulmonary Function in a Cohort of Patients with Interstitial Lung Disease and Positive for Antisynthetase Antibodies.
González-Pérez MI; Mejía-Hurtado JG; Pérez-Román DI; Buendía-Roldán I; Mejía M; Falfán-Valencia R; Mateos-Toledo HN; Rojas-Serrano J
J Rheumatol; 2020 Mar; 47(3):415-423. PubMed ID: 31203227
[TBL] [Abstract][Full Text] [Related]
46. Clinical profile of anti-PL-12 autoantibody. Cohort study and review of the literature.
Kalluri M; Sahn SA; Oddis CV; Gharib SL; Christopher-Stine L; Danoff SK; Casciola-Rosen L; Hong G; Dellaripa PF; Highland KB
Chest; 2009 Jun; 135(6):1550-1556. PubMed ID: 19225060
[TBL] [Abstract][Full Text] [Related]
47. Antiendothelial cell antibodies in inflammatory myopathies: distribution among clinical and serologic groups and association with interstitial lung disease.
D'Cruz D; Keser G; Khamashta MA; Direskeneli H; Targoff IN; Miller F; Hughes GR
J Rheumatol; 2000 Jan; 27(1):161-4. PubMed ID: 10648033
[TBL] [Abstract][Full Text] [Related]
48. A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease.
Patel P; Marinock JM; Ajmeri A; Brent LH
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674039
[TBL] [Abstract][Full Text] [Related]
49. Treatment of antisynthetase-associated interstitial lung disease with tacrolimus.
Wilkes MR; Sereika SM; Fertig N; Lucas MR; Oddis CV
Arthritis Rheum; 2005 Aug; 52(8):2439-46. PubMed ID: 16052580
[TBL] [Abstract][Full Text] [Related]
50. The prognostic value of HRCT in myositis-associated interstitial lung disease.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Aihara K; Ikezoe K; Watanabe K; Taguchi Y; Hatta K; Oga T; Chin K; Nagai S; Mimori T; Mishima M
Respir Med; 2013 May; 107(5):745-52. PubMed ID: 23485097
[TBL] [Abstract][Full Text] [Related]
51. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.
Hall JC; Casciola-Rosen L; Samedy LA; Werner J; Owoyemi K; Danoff SK; Christopher-Stine L
Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1307-15. PubMed ID: 23436757
[TBL] [Abstract][Full Text] [Related]
52. Proinflammatory Histidyl-Transfer RNA Synthetase-Specific CD4+ T Cells in the Blood and Lungs of Patients With Idiopathic Inflammatory Myopathies.
Galindo-Feria AS; Albrecht I; Fernandes-Cerqueira C; Notarnicola A; James EA; Herrath J; Dastmalchi M; Sandalova T; Rönnblom L; Jakobsson PJ; Fathi M; Achour A; Grunewald J; Malmström V; Lundberg IE
Arthritis Rheumatol; 2020 Jan; 72(1):179-191. PubMed ID: 31403245
[TBL] [Abstract][Full Text] [Related]
53. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
54. Clinical implications of autoantibody screening in patients with autoimmune myositis.
Ghirardello A; Zampieri S; Tarricone E; Iaccarino L; Bendo R; Briani C; Rondinone R; Sarzi-Puttini P; Todesco S; Doria A
Autoimmunity; 2006 May; 39(3):217-21. PubMed ID: 16769655
[TBL] [Abstract][Full Text] [Related]
55. Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.
Dugar M; Cox S; Limaye V; Blumbergs P; Roberts-Thomson PJ
Intern Med J; 2011 Sep; 41(9):674-9. PubMed ID: 20059602
[TBL] [Abstract][Full Text] [Related]
56. Predictive Features and Clinical Presentation of Interstitial Lung Disease in Inflammatory Myositis.
Vojinovic T; Cavazzana I; Ceruti P; Fredi M; Modina D; Berlendis M; Franceschini F
Clin Rev Allergy Immunol; 2021 Feb; 60(1):87-94. PubMed ID: 33141387
[TBL] [Abstract][Full Text] [Related]
57. Skeletal Muscle Involvement in Antisynthetase Syndrome.
Noguchi E; Uruha A; Suzuki S; Hamanaka K; Ohnuki Y; Tsugawa J; Watanabe Y; Nakahara J; Shiina T; Suzuki N; Nishino I
JAMA Neurol; 2017 Aug; 74(8):992-999. PubMed ID: 28586844
[TBL] [Abstract][Full Text] [Related]
58. [The clinical significance of myositis-specific antibodies in polymyositis/dermatomyositis associated interstitial lung diseases].
Xie MM; Yan X; Li H; Ding JJ; Gui XH; Liu Y; Wang YS; Chen ZY; Cai HR
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Aug; 41(8):616-621. PubMed ID: 30138971
[No Abstract] [Full Text] [Related]
59. Diagnosis of myositis-associated interstitial lung disease: Utility of the myositis autoantibody line immunoassay.
Jee AS; Parker MJS; Bleasel JF; Troy LK; Lau EM; Jo HE; Teoh AKY; Webster S; Adelstein S; Corte TJ
Respir Med; 2021 Oct; 187():106581. PubMed ID: 34454312
[TBL] [Abstract][Full Text] [Related]
60. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
